IP Library Granted Patent US 8,001,977
Granted Patent B2
US 8,001,977 · App. 11/400,620 · Granted Aug 23, 2011

Device for moving magnetic nanoparticles through tissue

Assignee: NanoBioMagnetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,001,977
App. No.
11/400,620
Granted
Aug 23, 2011
Kind
B2
Abstract

The movement of magnetically responsive nanoparticles through a membrane is significantly enhanced by using a varying magnetic field gradient. The magnetic field varies in intensity and/or direction and can be achieved by mechanically varying the position of a magnet with respect to the membrane, or by oscillating the strength of one or more electromagnets.

Claims (21)

1. A method of using a magnetic field to move magnetically responsive nanoparticles through a membrane within a body comprising the following step:

moving the nanoparticles through the membrane using a primary magnet to direct the nanoparticles in a primary direction, and at the same time, one or more secondary magnets directed at an acute angle relative to the primary direction, wherein the secondary magnets are controlled to repetitively vary the direction of the resultant magnetic field gradient in a pulsating manner.

2. The method of claim 1 wherein the magnetically responsive nanoparticles comprise ferromagnetic nanoparticles.

3. The method of claim 1 wherein the magnetically responsive nanoparticles comprise superparamagnetic nanoparticles.

4. The method of claim 1 wherein the membrane within the body comprises a tumor wall in a human body.

5. The method of claim 1 further comprising the step of embedding the nanoparticles in target cells.

6. The method of claim 5 wherein the nanoparticles carry a pharmaceutical.

7. The method of claim 6 wherein the pharmaceutical comprises a cancer-treating drug and the target cells are tumors.

8. The method of claim 5 wherein the nanoparticles impart magnetic properties to an organ comprising the target cells.

9. The method of claim 8 further comprising the step of applying magnetic stimuli to cause the organ to respond.

10. The method of claim 8 wherein the target cells are located in an ear of a human.

11. The method of claim 8 wherein the target cells are located in a valve of a human.

12. The method of claim 1 wherein the intensity of the magnetic field varies repetitively.

13. The method of claim 12 wherein the magnetic field intensity oscillates on and off.

14. The method of claim 1 wherein the magnetic field has an oscillating directional component.

15. The method of claim 1 , further comprising the initial step of introducing the magnetically responsive nanoparticles into the body.

16. The method of claim 1 , further comprising the step of positioning the primary and secondary magnets proximate the membrane.

17. The method of claim 1 , wherein the primary magnet supplies at least about 50 percent of the total magnetic field.

18. The method of claim 1 , wherein the secondary magnets are electromagnets, the electromagnets pulsed to provide the repetitively-varying magnetic field gradient at the membrane.

19. The method of claim 1 , utilizing two secondary electromagnets alternately pulsed to provide the repetitively-varying magnetic field gradient at the membrane.

20. The method of claim 1 , wherein the secondary magnets are moved or rotated about an axis in a manner to cause repetitive variation in the magnetic field gradient at the membrane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2013
From: NANOBIOMAGNETICS, INC
To: SWR&D INC.
Reel/Frame 029780/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2006
From: SEENEY, CHARLES E.; YUILL WILLIAM A.
To: NANOBIOMAGNETICS, INC.
Reel/Frame 017788/0747 →
Continuity (1)
Related Publication 20060228421A1 · Oct 12, 2006